Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: J Periodontol. 2008 Aug;79(8 Suppl):1592–1600. doi: 10.1902/jop.2008.080174

Figure 4.

Figure 4

MMP inhibition reduces disease activity in patients with severe periodontitis. Effect of SDD on clinical attachment loss ≥2 mm from baseline to 9 months. Tooth sites were stratified by degree of disease severity, based on PD at baseline. Mean per-patient percentages (± SE) are presented. The more severe the disease state, the greater the observed attenuation of disease activity by SDD therapy. Adapted from reference 22.

HHS Vulnerability Disclosure